BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) announced a new plan of work focusing on its proprietary CRM platform to meet the increased demand for medical cannabis in Israel. This follows recent regulatory reforms allowing cannabis as a first-line treatment, leading to a surge in licensed medical cannabis patients. The company's Benefit CRM helps optimize functions like sales management and asset management. The software development phase will focus on AI elements to increase data collection and analysis. In February 2023, BYND Cannasoft received a full license to trade in medical cannabis products.